Regenerative Medicine Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Regenerative Medicine Market
Regenerative Medicine Market: By Therapy (Cell therapy, Gene therapy, Tissue engineering, Small molecules and Biologics); By Product (Cell-Based Products and Acellular Product); By Material (Synthetic material, Biologically derived material, Pharmaceutical, and Others); By Application (Cardiology, Oncology, Dermatology, Ophthalmology, and Others); & By Geography – Forecast (2018–2023)
Report Code : HCR 0366
Updated Date: 02 January, 2019  
16

Copies sold

    Client Rating

1. Regenerative Medicine Market — Market Overview
1.1. Definitions and Scope
2. Regenerative Medicine Market — Executive Summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends Segmented by Geography
3. Regenerative Medicine Market — Market Landscape
3.1. Comparative Analysis
3.1.1. Product Benchmarking — Top 10 Companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value Split by Key Companies
3.1.4. Pricing Analysis
4. Regenerative Medicine Market — Startup Companies Scenario
4.1. Key Startup Company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Venture Capital and Funding Scenario
5. Regenerative Medicine Market — Industry Market Entry Scenario
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing Business Index
5.3. Case Studies of Successful Ventures
5.4. Customer Analysis — Key Companies
6. Regenerative Medicine Market — Market Forces
6.1. Drivers
6.2. Constraints & Challenges
6.3. Porter’s Five Force Model
6.3.1. Bargaining Power of Suppliers
6.3.2. Bargaining Power of Customers
6.3.3. Threat of New Entrants
6.3.4. Rivalry Among Existing Players
6.3.5. Threat of Substitutes
7. Regenerative Medicine Market — Strategic Analysis
7.1. Value Chain Analysis
7.2. Opportunities Analysis
7.3. Market Life Cycle
8. Regenerative Medicine Market — By Therapy (Market Size — $Million/$Billion)
8.1. Market Size and Market Share Analysis
8.2. Therapy Segment Analysis
8.2.1. Cell Therapy
8.2.2. Gene Therapy
8.2.3. Tissue Engineering
8.2.4. Others
9. Regenerative Medicine Market — By Product (Market Size — $Million/$Billion)
9.1. Market Size and Market Share Analysis
9.2. Product Segment Analysis
9.2.1. Cell-Based Products
9.2.1.1. Allogeneic Products
9.2.1.2. Autologous Products
9.2.2. Acellular Products
10. Regenerative Medicine Market — By Material (Market Size — $Million/$Billion)
10.1. Market Size and Market Share Analysis
10.2. Material Segment Analysis
10.2.1. Synthetic Material
10.2.1.1. Biodegradable Synthetic Polymers
10.2.1.2. Scaffold
10.2.1.3. Artificial Vascular Graft Materials
10.2.1.4. Hydrogel Materials
10.2.2. Biologically Derived Material
10.2.2.1. Collagen
10.2.2.2. Xenogeneic Material
10.2.3. Genetically Engineered Material
10.2.3.1. Genetically Manipulated Cells
10.2.3.2. 3D Polymer Technology
10.2.3.3. Transgenic
10.2.3.4. Fibroblast
10.2.3.5. Neural Stem Cells
10.2.3.6. Gene-activated Matrices
10.2.4. Pharmaceutical
10.2.4.1. Small Molecules
10.2.4.2. Biologics
11. Regenerative Medicine Market — By Application (Market Size — $Million/$Billion)
11.1. Market Size and Market Share Analysis
11.2. Application Segment Analysis
11.2.1. Orthopedic & Musculoskeletal
11.2.2. Cardiovascular
11.2.3. Oncology
11.2.4. Dermatology
11.2.5. Neurology
11.2.6. Ophthalmology
11.2.7. Hematology & Immunology
11.2.8. Diabetes
11.2.9. Esophagus
11.2.10. Dental
11.2.11. Others
12. Regenerative Medicine Market — By Geography (Market Size — $Million/$Billion)
12.1. Regenerative Medicine Market — North America Segment Research
12.2. North America Market Research (Market Size — $Million/$Billion)
12.2.1. Segment Size and Market Size Analysis
12.2.2. Revenue and Trends
12.2.3. Therapy Analysis
12.2.4. Product Industry Analysis
12.2.5. Material Industry Analysis
12.2.6. Application Analysis
12.2.7. North America Segment Analysis
12.2.7.1. U.S.
12.2.7.2. Canada
12.2.7.3. Mexico
12.3. Regenerative Medicine Market — South America Segment Research
12.4. South America Market Research (Market Size — $Million/$Billion)
12.4.1. Segment Size and Market Size Analysis
12.4.2. Revenue and Trends
12.4.3. Therapy Analysis
12.4.4. Product Industry Analysis
12.4.5. Material Industry Analysis
12.4.6. Application Analysis
12.4.7. South America Segment Analysis
12.4.7.1. Brazil
12.4.7.2. Chile
12.4.7.3. Argentina
12.4.7.4. Rest of South America
12.5. Regenerative Medicine Market — Europe Segment Research
12.6. Europe Market Research (Market Size — $Million/$Billion)
12.6.1. Segment Size and Market Size Analysis
12.6.2. Revenue and Trends
12.6.3. Therapy Analysis
12.6.4. Product Industry Analysis
12.6.5. Material Industry Analysis
12.6.6. Application Analysis
12.6.7. Europe Segment Analysis
12.6.7.1. U.K.
12.6.7.2. Germany
12.6.7.3. Italy
12.6.7.4. France
12.6.7.5. Russia
12.6.7.6. Spain
12.6.7.7. Rest of Europe
12.7. Regenerative Medicine Market — APAC Segment Research
12.8. Asia Pacific Market Research (Market Size — $Million/$Billion)
12.8.1. Segment Size and Market Size Analysis
12.8.2. Revenue and Trends
12.8.3. Therapy Analysis
12.8.4. Product Industry Analysis
12.8.5. Material Industry Analysis
12.8.6. Application Analysis
12.8.7. APAC Segment Analysis
12.8.7.1. China
12.8.7.2. Australia
12.8.7.3. Japan
12.8.7.4. South Korea
12.8.7.5. India
12.8.7.6. Rest of APAC
12.9. Regenerative Medicine Market — Middle East Segment and Africa Segment Research
12.10. Middle East and Africa Market Research (Market Size — $Million/$Billion)
12.10.1. Segment type Size and Market Size Analysis
12.10.2. Revenue and Trends
12.10.3. Therapy Analysis
12.10.4. Product Industry Analysis
12.10.5. Material Industry Analysis
12.10.6. Application Analysis
12.10.7. Middle East & Africa Segment Analysis
12.10.7.1. Middle East
12.10.7.2. Africa
13. Regenerative Medicine Market — Market Entropy
14. Regenerative Medicine Market — Key Company List by Country
15. Regenerative Medicine Market Company Analysis
15.1. Market Share, Company Revenue, Products, M&A, Developments
15.2. Vertex Pharmaceuticals Inc. (U.S.)
15.3. Medtronic Plc (Ireland)
15.4. NuVasive, Inc. (U.S.)
15.5. Integra LifeSciences  Holdings Corporation (U.S.)
15.6. Smith & Nephew Plc (U.K.)
15.7. Mesoblast Ltd. (Australia)
15.8. Vericel Corporation (U.S.)
15.9. Athersys, Inc. (U.S.)
15.10. Exactech, Inc. (U.S.) 
15.11. Company 10
15.12. Company 11
15.13. Company 12 and more
"*Financials of private companies will be provided on a best-efforts basis"
16. Regenerative Medicine Market — Appendix
16.1. Abbreviations
16.2. Sources
17. Regenerative Medicine Market — Methodology
17.1. Research Methodology
17.1.1. Company Expert Interviews
17.1.2. Industry Databases
17.1.3. Associations
17.1.4. Company News
17.1.5. Company Annual Reports
17.1.6. Application Trends
17.1.7. New Products and Product Database
17.1.8. Company Transcripts
17.1.9. R&D Trends
17.1.10. Key Opinion Leaders Interviews
17.1.11. Supply and Demand Trends
Please select Licence
Single User Licence:
US $5250
Corporate User Licence:
US $7250
Related Reports
0px;">Scroll